Literature DB >> 15505270

The impact of new guidelines for glucose tolerance testing on clinical practice and laboratory services.

Andrew W Lyon1, Erik T Larsen, Alun L Edwards.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15505270      PMCID： PMC526333          DOI： 10.1503/cmaj.1040138

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  19 in total

1.  The folly of population screening for type 2 diabetes.

Authors:  K G Marshall
Journal:  CMAJ       Date:  1999-06-01       Impact factor: 8.262

2.  Identifying the target population for primary prevention: the trade-offs.

Authors:  Michael M Engelgau; K M Venkat Narayan; Frank Vinicor
Journal:  Diabetes Care       Date:  2002-11       Impact factor: 19.112

3.  The reproducibility and usefulness of the oral glucose tolerance test in screening for diabetes and other cardiovascular risk factors.

Authors:  G T Ko; J C Chan; J Woo; E Lau; V T Yeung; C C Chow; C S Cockram
Journal:  Ann Clin Biochem       Date:  1998-01       Impact factor: 2.057

4.  Reproducibility and comparative analysis of repeated intravenous and oral glucose tolerance tests.

Authors:  O P Ganda; J L Day; J S Soeldner; J J Connon; R E Gleason
Journal:  Diabetes       Date:  1978-07       Impact factor: 9.461

5.  Impact of new diagnostic criteria for diabetes on different populations.

Authors:  J E Shaw; M de Courten; E J Boyko; P Z Zimmet
Journal:  Diabetes Care       Date:  1999-05       Impact factor: 19.112

Review 6.  Clinical impact of the new criteria for the diagnosis of diabetes mellitus.

Authors:  Andrew F B Kernohan; Colin G Perry; Michael Small
Journal:  Clin Chem Lab Med       Date:  2003-09       Impact factor: 3.694

Review 7.  1998 clinical practice guidelines for the management of diabetes in Canada. Canadian Diabetes Association.

Authors:  S Meltzer; L Leiter; D Daneman; H C Gerstein; D Lau; S Ludwig; J F Yale; B Zinman; D Lillie
Journal:  CMAJ       Date:  1998       Impact factor: 8.262

8.  Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group.

Authors: 
Journal:  BMJ       Date:  1998-08-08

9.  Diagnostic strategies to detect glucose intolerance in a multiethnic population.

Authors:  Sonia S Anand; Fahad Razak; Vlad Vuksan; Hertzel C Gerstein; Klas Malmberg; Qilong Yi; Koon K Teo; Salim Yusuf
Journal:  Diabetes Care       Date:  2003-02       Impact factor: 19.112

10.  Reproducibility of S-insulin and B-glucose responses in two identical oral glucose tolerance tests.

Authors:  K Schousboe; J E Henriksen; K O Kyvik; T I A Sørensen; P Hyltoft Petersen
Journal:  Scand J Clin Lab Invest       Date:  2002       Impact factor: 1.713
View more
  6 in total

1.  How to diagnose diabetes.

Authors:  Gina Agarwal
Journal:  CMAJ       Date:  2005-03-01       Impact factor: 8.262

2.  How to diagnose diabetes.

Authors:  Gurusamy Sivagnanam
Journal:  CMAJ       Date:  2005-03-01       Impact factor: 8.262

Review 3.  HbA1c for screening and diagnosis of diabetes mellitus.

Authors:  Trefor Higgins
Journal:  Endocrine       Date:  2012-08-21       Impact factor: 3.633

4.  Trends in laboratory testing for diabetes in Ontario, Canada 1995-2005: a population-based study.

Authors:  Sarah E Wilson; Lorraine L Lipscombe; Laura C Rosella; Douglas G Manuel
Journal:  BMC Health Serv Res       Date:  2009-02-27       Impact factor: 2.655

5.  Diabetes and pre-diabetes among persons aged 35 to 60 years in eastern Uganda: prevalence and associated factors.

Authors:  Roy William Mayega; David Guwatudde; Fredrick Makumbi; Frederick Nelson Nakwagala; Stefan Peterson; Goran Tomson; Claes-Goran Ostenson
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240

6.  Clinical presentation of newly diagnosed diabetes patients in a rural district hospital in Eastern Uganda.

Authors:  Roy William Mayega; Elizeus Rutebemberwa
Journal:  Afr Health Sci       Date:  2018-09       Impact factor: 0.927
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.